A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study is designed to evaluate the effectiveness of NOE-105 on speech fluency without the known antipsychotic-induced side effects of commonly used treatments for childhood onset fluency disorder (COFD).
Epistemonikos ID: 3cdc015a826bb71214331b6bc19f40aec64602fb
First added on: May 14, 2024